Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Saga rose more than 17%, breaking through $2.86, and recently launched a new token economy model

Saga rose more than 17%, breaking through $2.86, and recently launched a new token economy model

依始2024/09/25 06:28
Saga has risen 17.32% in the past 24 hours, with a current price of $2.6797 and a high of $2.8699 during the day, with a surge in market trading volume.
 
According to the latest developments of the project, on September 21st, Saga launched a new token economy model with the core highlight of "zero-cost infrastructure", providing developers with an almost free Development Environment. The new model not only allows developers to focus on innovation and experimentation without worrying about high infrastructure costs, but also introduces a cost structure of front-end and back-end separation. Front-end users do not need to pay Gas fees, while all transaction fees are returned to developers. In addition, Saga also launched a "Gas fee recovery" mechanism, allowing developers to further reduce usage costs by recycling Gas tokens, providing a seamless and cost-free User Experience.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Deutsche Bank believes that the continuously expanding chip trade surplus in Asia is becoming a supporting force for the US dollar, as related profits are increasingly being reinvested into the US stock market.

智通财经•2026/11/16 23:03
The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Roche's (RHHBY.US) new breast cancer drug Wilserdly approved by FDA: Analysts predict peak annual sales could reach up to $14.5 billion

Roche's (RHHBY.US) new oral breast cancer drug has been approved by U.S. regulators, paving the way for this medication, which the pharmaceutical company hopes will transform the treatment of the disease.

智通财经•2026/11/16 22:53

Soros Family Office Leads in Reducing Nvidia Holdings, Top Billionaires Cashed Out Quietly Before Jensen Huang's Departure

Several ultra-high-net-worth family offices collectively reduced their holdings in Nvidia during Q3, including the Soros Family Office, BlueCrest, and Abu Dhabi sovereign investment institutions. This move secured profits just before CEO Jensen Huang was dismissed by the board on November 12 due to an extramarital affair scandal. More than ten institutions participated in the reduction, although all retained some holdings, with the combined market value of their shares still exceeding $1 billion. Meanwhile, some institutions continued to increase their positions against the trend.

华尔街见闻•2026/11/16 22:41